Systematic Reviews
Copyright ©The Author(s) 2015.
World J Orthop. Jul 18, 2015; 6(6): 491-497
Published online Jul 18, 2015. doi: 10.5312/wjo.v6.i6.491
Table 1 Functional classification of postsurgical outcome for Achilles tendinopathy[8]
RatingResult
ExcellentNo residual symptoms, sports performance unlimited
GoodFull return to the same sport as preoperatively; some stiffness after strenuous activities
FairImprovement with regard to the preoperative situation; still stiffness and aching relating to sports
PoorNo improvement at all
Table 2 Coleman Methodology Score criteria for studies reporting the outcomes of surgery for Achilles tendinopathy[9]
SectionNumber or factorScore
Part A - only one score to be given for each of the seven sections
Study size - number of tendons (N) (if multiple follow-up, multiply N by number of times subjects followed up)> 6010
41-607
20-404
< 20, not stated0
Mean follow-up (mo)> 245
12-242
< 12, not stated, or unclear0
Number of different surgical procedures included in each reported outcome. More than one surgical technique may be assessed but separate outcomes should be reportedOne surgical procedure only10
More than one surgical procedure, but > 90% of subjects undergoing the one procedure7
Not stated, unclear, or < 90% of subjects undergoing the one procedure0
Type of studyRandomized control trial15
Prospective cohort study10
Retrospective cohort study0
Diagnostic certainty (use of preoperative ultrasound, MRI, or postoperative histopathology to confirm diagnosis)In all5
In > 80%3
In < 80%, not stated, or unclear0
Description of surgical procedure givenAdequate (technique stated and necessary details of that type of procedure given)5
Fair (technique only stated without elaboration)3
Inadequate, not stated, or unclear0
Description of postoperative rehabilitationWell described with > 80% of patients complying10
Well described with 60%-80% of patients complying5
Protocol not reported or < 60%-80% of patients complying0
Part B - scores may be given for each option in each of the three sections if applicable
Outcome criteria (if outcome criteria is vague and does not specify subjects’ sporting capacity, score is automatically 0 for this section)Outcome measures clearly defined2
Timing of outcome assessment clearly stated (e.g., at best outcome after surgery or at follow-up)2
Use of outcome criteria that has reported good reliability3
Use of outcome with good sensitivity3
Procedure for assessing outcomesSubjects recruited (results not taken from surgeons’ file)5
Investigator independent of surgeon4
Written assessment3
Completion of assessment by subjects themselves with minimal investigator assistance3
Description of subject selection processSelection criteria reported and unbiased5
Recruitment rate reported: > 80% or < 80%5
Eligible subjects not included in the study satisfactorily accounted for or 100% recruitment5
Table 3 Mean Scores for each of the 10 Coleman Methodology Score criteria for all included studies
Methodology criteria (maximum score)Mean
Range
ScoreSD
Part A
Study size (10)4.54.60-10
Follow-up (10)3.32.40-5
No. of procedures (10)6.650-10
Type of study (15)3.45.40-10
Diagnostic certainty (5)1.92.50-5
Description of surgical technique (5)4.11.80-5
Rehabilitation and compliance (10)4.850-10
Part B
Outcome criteria (10)4.73.70-10
Outcome assessment (15)5.24.50-12
Selection process (15)4.660-15
Methodology score (100)40.118.92-79
Table 4 Coleman Methodology Scores for all included studies
Ref.Year of studyMean follow-up (mo)N Tendons% SuccessColeman Methodology Scores
Snook[10]197243
Burry and Pool[11]197352
Clancy et al[12]197655
Denstad and Roaas[13]19795846
Gould and Korson[14]1980128
Kvist and Kvist[15]19802019735
Leach et al[16]19812010
Subotnick and Sisney[17]19864215
Saillant et al[18]198742658636
Schepsis and Leach[19]198736458744
Nelen et al[8]19891436741
Leppilahti et al[20]19911508612
Anderson et al[21]199252489427
Clement et al[22]1992691413
Leach et al[23]199212858
Leppilahti et al[24]1994482757350
Schepsis et al[25]1994797966
Aström and Rausing[26]199516343
Alfredson et al[6]1996121360
Johnston et al[27]1997244122
Maffulli et al[28]199722527170
Morberg et al[29]199772646774
Rolf and Movin[5]199725607569
Alfredson et al[30]1998121159
Maffulli et al[31]199935143656
Paavola et al[32]2000514259
Wilcox et al[33]2000142032
Ohberg et al[34]200160249265
Shalabi et al[35]200124158751
Maquirriain et al[36]200216737
Paavola et al[37]200274246
Shalabi et al[38]200224158051
Yodlowski et al[39]2002394139
Chiara Vulpiani et al[40]2003156868835
Den Hartog et al[41]200335298834
Saxena[42]2003563710017
Martin et al[43]2005414452
Costa et al[44]2006902127
Johnson et al[45]2006342232
Maffulli et al[46]200637938174
Wagner et al[47]2006408129
Alfredson et al[2]200762061
Cottom et al[48]200827629537
Hahn et al[49]2008461338
Maffulli et al[50]200840867379
Vega et al[51]200824810051
Bohu et al[52]20094213729
Thermann et al[53]20096837
Will et al[54]2009221934
Duthon et al[55]201124177948
van Sterkenburg et al[56]201112310044
Maffulli et al[57]201136308554
Sarimo et al[58]2011302410042
Oshri et al[59]2012216243
Kiewiet et al[60]2013351230
Maffulli et al[61]2013204397742
Maquirriain[62]201392279647
Benazzo et al[63]2014485260
Tallerico et al[64]2014141128
Maffulli et al[65]2015541810038
Nawoczenski et al[66]201518138552